| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |